Big Buttons

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Compounding vs. counterfeit — ABC News gets it

  When ABC News wanted to do a story on compounded GLP-1s, it turned to APC. Of course. read more →

• No no, Novo!

  Novo Nordisk asked the FDA to put semaglutide on the Demonstrably Difficult to Compound (DDC) list, and now APC has formally responded, pulling exactly zero punches. read more →

• About that Diabetes Association statement …

  The American Diabetes Association gets a good portion of its funding from pharmaceutical companies, including Eli Lilly and Novo Nordisk. read more →

• Foundation welcomes 2025 board members

  Congratulations to the newest members of the Pharmacy Compounding Foundation Board of Directors read more →

• End Drug Shortages Act intro’d in Congress

  The legislation would expand the sources the FDA may use to declare drug shortages. read more →

• FDA tirzepatide ‘reconsideration’ period extended

  FDA agreed to extend until December 19 a final report on tirzepatide availability to the court.  read more →

• NPR hits the GLP-1 nail on the head

  A National Public Radio piece this week tackled the issue of compounded GLP-1 drugs and got the facts and nuance just right. read more →

More News

When ABC News wanted to do a story on compounded GLP-1s — how they’re made and regulated, and how legit compounders are very different than pop-up shops — it turned to APC. Of course.

In “A Shot in the Dark,” Host Eva Pilgrim looked, of course, at the myriad benefits of those drugs, and how life-changing they’ve been for patients. But the piece wasn’t yet another “Are compounded drugs safe?” story. Instead, it focused on (with help from APC CEO Scott Brunner) the crucial difference between drugs from licensed compounding pharmacies and those from shady online ‘wellness clinics.’ 

It’s one of the first major news stories we’ve seen that not only made that distinction, but specifically focused on it. 

“The bogus actors are a scourge,” Scott said. “Unfortunately the drug makers themselves continue to conflate the two. They will refer in their public statements to ‘compounding and counterfeit drugs’ as if those are one and the same, and they are decidedly not.” (In fact, to showcase the quality control of legitimate compounding pharmacies, the video includes a tour of APC Board Chair Joe Navarra’s Total Town Compounding Center on Long Island. )

The piece was big enough that it aired three times: a short version on ABC Evening News, a longer version on “Good Morning America,” and then the full, 24-minute segment on ABC News Live (online and streaming) that you can watch:

ABC is just the latest news outlet to turn to APC for information about compounded drugs in general, and GLP-1 agonists in particular. See where else we’ve been featured at a4pc.org/inthenews.